Immune Globulin Subcutaneous (Human), 20% Solution

immune globulin subcutaneous (human), 20% solution · Takeda

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Immune Globulin Subcutaneous (Human), 20% Solution, covering 2026-02-20 to 2026-02-20. Get the full timeline:

Most recent: Clinical Trial Update: A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary Immunodeficiency

See pricing